Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Galit Alter

Showing results (511-520 of 535) with videos related to

Pageof 54
Sort By:
Ebiomedicine|March 29, 2025
Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trialsChristopher L Cooper, Gavin Morrow, Maoli Yuan, et al.
Annals of the New York Academy of Sciences|April 6, 2023
Progress in vaccine development for infectious diseases-a Keystone Symposia reportJennifer Cable, Barney S Graham, Richard A Koup, et al.
Nature Medicine|January 16, 2018
Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccineScott G Hansen, Daniel E Zak, Guangwu Xu, et al.
Science Immunology|December 3, 2021
A particulate saponin/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunityMurillo Silva, Yu Kato, Mariane B Melo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 29, 2020
Clinical sensitivity and interpretation of PCR and serological COVID-19 diagnostics for patients presenting to the hospitalTyler E Miller, Wilfredo F Garcia Beltran, Adam Z Bard, et al.
Science Immunology|October 15, 2021
Early cross-coronavirus reactive signatures of humoral immunity against COVID-19Paulina Kaplonek, Chuangqi Wang, Yannic Bartsch, et al.
Nature Medicine|September 5, 2020
Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamstersLisa H Tostanoski, Frank Wegmann, Amanda J Martinot, et al.
JAMA|March 11, 2021
Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19Kathryn E Stephenson, Mathieu Le Gars, Jerald Sadoff, et al.
Cell|August 11, 2018
Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to ProtectionErica Ollmann Saphire, Sharon L Schendel, Marnie L Fusco, et al.
Nature Medicine|July 12, 2016
International AIDS Society global scientific strategy: towards an HIV cure 2016Steven G Deeks, Sharon R Lewin, Anna Laura Ross, et al.
Pageof 54

Showing results (511-520 of 535) with videos related to

Sort By:
Pageof 54
Ebiomedicine|March 29, 2025
Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trialsChristopher L Cooper, Gavin Morrow, Maoli Yuan, et al.
Annals of the New York Academy of Sciences|April 6, 2023
Progress in vaccine development for infectious diseases-a Keystone Symposia reportJennifer Cable, Barney S Graham, Richard A Koup, et al.
Nature Medicine|January 16, 2018
Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccineScott G Hansen, Daniel E Zak, Guangwu Xu, et al.
Science Immunology|December 3, 2021
A particulate saponin/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunityMurillo Silva, Yu Kato, Mariane B Melo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 29, 2020
Clinical sensitivity and interpretation of PCR and serological COVID-19 diagnostics for patients presenting to the hospitalTyler E Miller, Wilfredo F Garcia Beltran, Adam Z Bard, et al.
Science Immunology|October 15, 2021
Early cross-coronavirus reactive signatures of humoral immunity against COVID-19Paulina Kaplonek, Chuangqi Wang, Yannic Bartsch, et al.
Nature Medicine|September 5, 2020
Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamstersLisa H Tostanoski, Frank Wegmann, Amanda J Martinot, et al.
JAMA|March 11, 2021
Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19Kathryn E Stephenson, Mathieu Le Gars, Jerald Sadoff, et al.
Cell|August 11, 2018
Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to ProtectionErica Ollmann Saphire, Sharon L Schendel, Marnie L Fusco, et al.
Nature Medicine|July 12, 2016
International AIDS Society global scientific strategy: towards an HIV cure 2016Steven G Deeks, Sharon R Lewin, Anna Laura Ross, et al.
Pageof 54